数据链接：
官方服务：
资源简介：
Phase 4 participant demographics by site.
应用场景：
创建时间：
2021-10-20
相关数据集
Supplementary Material for: Effectiveness and Safety of Golimumab in the Treatment of Ulcerative Colitis: 52-week Results from Post-marketing Surveillance in Japan
Introduction: Real-world evidence for the effectiveness and safety of golimumab (GLM) in patients with ulcerative colitis (UC) is limited. The aim of this study was to investigate the 52-week effectiv
Figshare2022-11-18 更新90
Demographic Measures.
The table displays the demographic details for the participants in the study. Following randomization, the two treatment groups were not statistically significantly different in age (p = 0.096), years
Figshare2015-12-02 更新40
Demographics of the included registered trial protocols.
Demographics of the included registered trial protocols.
Figshare2017-08-05 更新30
Time Series Analysis of the Effectiveness and Safety of Capsule Endoscopy between the Premarketing and Postmarketing Settings: A Meta-Analysis
Background Clinical studies for assessing the effectiveness and safety in a premarketing setting are conducted under time and cost constraints. In recent years, postmarketing data analysis has been gi
NIAID Data Ecosystem60
Real-world evidence of the safety and efficacy profile of suvorexant in elderly patients with insomnia: a sub-analysis of the post-marketing drug-use results survey in Japan
Objective: Global Phase III trials of suvorexant showed no obvious differences in the safety and efficacy profile of suvorexant between elderly and non-elderly patients. However, the clinical profile
Figshare2019-12-30 更新40
